ONWARD Medical Appoints Fouad Azzam to Board of Directors

ONWARD Medical N.V., a leader in neurotechnology focused on spinal cord stimulation, has announced the appointment of Fouad Azzam as a non-executive member of its Board of Directors. Azzam, a partner at EQT Life Sciences, brings extensive experience in supporting fast-growing medical technology and life sciences companies.

Dave Marver, CEO of ONWARD Medical, highlighted Azzam's relevant experience with growth-stage medical device companies. Azzam expressed enthusiasm for contributing to ONWARD's mission of enhancing access to spinal cord therapies and advancing their pipeline of technologies.

Fouad Azzam has a rich background, including roles at Eastman Ventures and Eastman Chemical Company, and holds a PhD in Chemical Engineering and an MBA. His expertise is expected to play a significant role as ONWARD scales its operations.